Peptable

Comparison

TB-500 vs Thymosin Alpha-1

Function

While TB-500 is studied for enhancing musculoskeletal and cardiac repair, wound healing, and promoting cell migration and differentiation via actin cytoskeleton remodeling21255, Thymosin Alpha-1 is clinically used in some countries as an immunomodulator for chronic hepatitis B/C and as an adjuvant in cancer therapy, enhancing cell-mediated immunity41487.

Mechanism

While TB-500 works as a synthetic peptide comprising the LKKTETQ actin-binding motif of thymosin beta-4 that binds G-actin, sequesters actin monomers, and promotes cell migration, angiogenesis, and tissue repair1255, Thymosin Alpha-1 is a 28-amino-acid thymic peptide fragment of prothymosin alpha that activates dendritic cells and T cells primarily via TLR9/MyD88/NF-κB signaling, enhancing Th1 responses and NK-cell cytotoxicity414.

Receptor

TB-500

Binds monomeric actin (G-actin) rather than a classical cell-surface receptor, modulating actin polymerization at barbed and pointed ends55

Thymosin Alpha-1

Toll-like receptors, predominantly TLR9 (and also TLR2/TLR3) on plasmacytoid dendritic cells and other immune cells4

Organism or Origin

TB-500

Synthetic derivative of human thymosin beta-4, whose full-length 43-amino-acid protein is abundant in mammalian tissues21279

Thymosin Alpha-1

Endogenous fragment of human prothymosin alpha produced in the thymus1487

Gene

TB-500

TMSB4X

Thymosin Alpha-1

PTMA

Summary

TB-500 and Thymosin Alpha-1 sit closest together within the Thymosin family, which gives them a broadly related biological identity. Their typical research and application settings separate fairly clearly: TB-500 is more often discussed in the realm of Musculoskeletal health and Cardiovascular health, whereas Thymosin Alpha-1 is more often associated with the realm of Immunology and inflammation and Oncology. Both appear to work through Signaling modulator, but the functional emphasis still separates, with TB-500 leaning toward Tissue repair and healing and Angiogenesis modulation and Thymosin Alpha-1 leaning toward Immune regulation. TB-500 has a more synthetic analog origin, while Thymosin Alpha-1 is closer to natural endogenous background and their development context also differs, with TB-500 in Preclinical development while Thymosin Alpha-1 is approved. Thymosin Alpha-1 incorporates acetylation features that are not part of TB-500.

Sources

2TB-500 (Thymosin Beta-4) | Peptide Biologix, https://peptidebiologix.com/tb-500
12Thymosin Beta-4 vs TB-500 | What to Know in 2024, https://www.peptidesciences.com/peptide-research/thymosin-beta-4-vs-tb-500
79TMSB4X Gene: Function, Research, and Clinical Applications, https://learn.mapmygenome.in/genemap/tmsb4x
4Thymosin Alpha-1: Thymic Immunomodulatory Peptide and ..., https://peptpedia.org/research/thymosin-alpha1-t-cell-immunomodulation
14Thymosin Alpha 1 - CPC Scientific, https://cpcscientific.com/products/catalog-peptides/THYM-004/
87PTMA protein | Thymosin alpha 1 Protein-NP_001092755.1, https://www.mybiosource.com/ptma-protein/thymosin-alpha-1/846997